Niclocide Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 500 mg
Reference Brands: Niclocide(US)
Category:
Anthelmintic
Niclosamide tablets inhibit mitochondrial respiration in tapeworms, disrupting their energy production and causing paralysis and death. It effectively treats intestinal tapeworm infections, providing rapid symptom relief, parasite elimination, and preventing transmission. Benefits include safe, effective eradication of parasites and improved gastrointestinal health.
Niclocide tablet is available in Tablets
and strengths such as 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Niclocide tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Niclocide tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Niclosamide tablets, marketed as Niclocide and generics, are approved in the US and EU mainly for intestinal tapeworm infections. Regulatory approval requires comprehensive dossiers, including clinical efficacy, safety profiles, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and manufacturing data, while the EMA ensures regional safety and quality compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe use, and global availability, enabling effective treatment of cestode infections worldwide and supporting gastrointestinal health in regions with parasitic disease burdens.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing